The Attenuation of Pain Behavior and Serum COX-2 Concentration by Curcumin in a Rat Model of Neuropathic Pain

키워드

참고문헌 (41)

1. Blackburn-Munro G, "Pain-like behaviours in animals - how human are they?", Trends Pharmacol Sci, 25, pp.299~305 (2004)
2. Zimmermann M, "Pathobiology of neuropathic pain", Eur J Pharmacol, 429, pp.23~37 (2001)
3. Campbell JN, "Mechanisms of neuropathic pain", Neuron, 52, pp.77~92 (2006)
4. Dray A, "Neuropathic pain : emerging treatments", Br J Anaesth, 101, pp.48~58 (2008)
5. Suzuki R, "Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury", Exp Neurol, 198, pp.72~80 (2006)
6. Epstein J, "Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies", Br J Nutr, 103, pp.1545~1557 (2010)
7. Sharma S, "Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain", Eur J Pharmacol, 536, pp.256~261 (2006)
8. Oh SW, "Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition", J Ethnopharmacol, 136, pp.414~421 (2011)
9. Sharma S, "Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain : participation of nitric oxide and TNF-alpha", Phytother Res, 21, pp.278~283 (2007)
10. Mittal N, "Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat", Phytother Res, 23, pp.507~512 (2009)
11. Chattopadhyay I, "Turmeric and curcumin : biological actions and medicinal applications", Curr Sci, 87, pp.44~53 (2004)
12. Stock JL, "The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure", J Clin Invest, 107, pp.325~331 (2001)
13. Luo C, "Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial", Acta Pharmacol Sin, 26, pp.926~933 (2005)
14. Neuss H, "The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs", J Mol Med (Berl), 85, pp.961~970 (2007)
15. Rainsford KD, "Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide", Inflammopharmacology, 14, pp.120~137 (2006)
16. Kimura T, "Suppressive effect of selective cyclooxygenase-2inhibitor on cytokine release in human neutrophils", Int Immunopharmacol, 3, pp.1519~1528 (2003)
17. Rang HP, "Anti-inflammatory and immunosuppressant drugs. In: Rang and Dale pharmacology", pp.232~ (2007), Churchill Livingston
18. Bryant DM, "Rheumatoid arthritis and osteoarthritis. In: Clinical pharmacy and therapeutics", pp.791~812 (2007), Churchill Livingstone
19. Shishodia S, "Curcumin : getting back to the roots", Ann N Y Acad Sci, 1056, pp.206~217 (2005)
20. Menon VP, "Antioxidant and anti-inflammatory properties of curcumin", Adv Exp Med Biol, 595, pp.105~125 (2007)
21. Zimmermann M, "Ethical guidelines for investigations of experimental pain in conscious animals", Pain, 16, pp.109~110 (1983)
22. Bennett GJ, "A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man", Pain, 33, pp.87~107 (1988)
23. Stuesse SL, "Neuropathic pain in aged rats: behavioral responses and astrocytic activation", Exp Brain Res, 137, pp.219~227 (2001)
24. Schaible HG, "Update on peripheral mechanisms of pain : beyond prostaglandins and cytokines", Arthritis Res Ther, 13, pp.210~ (2011)
25. Kohli K, "Curcumin : a natural antiinflammatory agent", Indian J Pharmacol, 37, pp.141~147 (2005)
26. Lim GP, "The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse", J Neurosci, 21, pp.8370~8377 (2001)
27. Li Y, "Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model", Int J Med Sci, 10, pp.377~381 (2013)
28. Jeon Y, "Curcumin could prevent the development of chronic neuropathic pain in rats with peripheral nerve injury", Curr Ther Res Clin Exp, 74, pp.1~4 (2013)
29. 김채은, "Curcumin의 신경병증성 통증 억제효과", 한국약용작물학회지, 16(3), pp.183~187 (2008), 한국약용작물학회
30. Yong Ku Han, "Analgesic Effects of Intrathecal Curcumin in the Rat Formalin Test", The Korean Journal of Pain, 25(1), pp.1~6 (2012), 대한통증학회
31. Bengmark S, "Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases", JPEN J Parenter Enteral Nutr, 30, pp.45~51 (2006)
32. Yeon KY, "Curcumin produces an antihyperalgesic effect via antagonism of TRPV1", J Dent Res, 89, pp.170~174 (2010)
33. Tajik H, "Interaction between curcumin and opioid system in the formalin test of rats", Pak J Biol Sci, 10, pp.2583~2586 (2007)
34. Chainani-Wu N, "Safety and anti-inflammatory activity of curcumin : a component of tumeric(Curcuma longa)", J Altern Complement Med, 9, pp.161~168 (2003)
35. Robert A. Orlando, "Inhibition of Nuclear Factor κB Activation and Cyclooxygenase-2 Expression by Aqueous Extracts of Hispanic Medicinal Herbs", Journal of Medicinal Food, 13(4), pp.888~895 (2010), 한국식품영양과학회
36. Tegeder I, "Effects of selective COX-1 and-2 inhibition on formalinevoked nociceptive behaviour and prostaglandin E(2)release in the spinal cord", J Neurochem, 79, pp.777~786 (2001)
37. in the spinal cord, "Prog Neurobiol", 2001, 327~363
38. Kang G, "Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells", J Pharmacol Sci, 94, pp.325~328 (2004)
39. Hinz B, "Cyclooxygenase-2--10 years later", J Pharmacol Exp Ther, 300, pp.367~375 (2002)
40. Ma W, "Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury", Neuroscience, 121, pp.691~704 (2003)
41. Aggarwal BB, "Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases", Int J Biochem Cell Biol, 41, pp.40~59 (2009)

관련 논문AI추천